Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News

Finerenone, sotagliflozin exert heart failure benefits despite renal dysfunction
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 14, 2021
News

VEST: External sheath for CABG vein grafts shows promise
- Author:
- Mitchel L. Zoler, PhD
Publish date: November 13, 2021
News

SURPASS-4: ‘Twincretin’ tirzepatide surpasses insulin glargine in pivotal trial
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 26, 2021
News

Researchers parse which patients with T2D need SGLT2 inhibition
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 26, 2021
News
To tackle obesity, up fitness and activity or lose weight?
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 22, 2021
News
Dropping weight beneficial but some effects of obesity persist
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 19, 2021
News
Men die more often than women after bariatric surgery
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 6, 2021
News

Primary goal in T2D should be weight loss, diabetologists say
- Author:
- Mitchel L. Zoler, PhD
Publish date: October 5, 2021
News
Women with type 2 diabetes get fewer cardioprotective drugs than do men
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 29, 2021
News

EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 20, 2021
News

Texts boost activity, quality of life in patients with heart failure and diabetes
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 16, 2021
News

PRESERVED-HF: Dapagliflozin improves physical limitations in patients with HFpEF
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 14, 2021
News

STOP-DAPT 2 ACS: 1 month of DAPT proves inadequate for patients with recent ACS
- Author:
- Mitchel L. Zoler, PhD
Publish date: September 9, 2021
News
EMPEROR-Preserved spouts torrent of reports on empagliflozin treatment of HFpEF
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 31, 2021
News

FIDELITY: Finerenone benefits patients with T2D across CKD spectrum
- Author:
- Mitchel L. Zoler, PhD
Publish date: August 28, 2021